Plasmids containing the foot-and-mouth disease virus structural protein precursor (P1) and 3C protease genes or the P1 gene alone were expressed in Escherichia coli. A recombinant baculovirus containing the P1 gene was also generated and expressed in Spodopterafrugiperda cells. Expression of the P1 and 3C genes in E. coli resulted in efficient synthesis and processing of the structural protein precursor and assembly into 70S empty capsids. This material reacted with neutralizing monoclonal antibodies which recognize only conformational epitopes and elicited a significant neutralizing antibody response in vaccinated guinea pigs. Expression of the P1 gene in E. coli resulted in synthesis of an insoluble product, whereas in insect cells infected with the recombinant baculovirus a soluble product was synthesized. Both soluble and insoluble P1 reacted with a 12S-specific monoclonal antibody, but only soluble P1 elicited a neutralizing antibody response in guinea pigs.
Foot-and-mouth disease (FMD) is a major pathogen of ruminants in many parts of the world. The disease is caused by members of the Aphthovirus genus of the Picornaviridae family. An inactivated virus vaccine is used in disease control programs, and it has been estimated that worldwide more than a billion doses of the vaccine are used annually (3) . Concern about the safety of the vaccine exists, as outbreaks of FMD in Europe have been associated with shortcomings in vaccine manufacture (25) . These concerns have led to efforts to develop subunit vaccines as safer alternatives. One of the virus capsid proteins, VP1, either purified from virus particles or produced by recombinant DNA technology, has been successfully used to protect cattle and swine from challenge (4, 26) . Likewise, peptides either produced by recombinant DNA technology or chemically synthesized and representing limited regions of VP1 have also been successfully used to protect cattle and swine against challenge with some serotypes of FMD virus (FMDV) (8, 15, 30) . However, relatively large amounts of these immunogens were required to produce protection, and often induction of a neutralizing antibody response with these immunogens, as measured by in vitro assays, did not correlate with protection of the host animal (7) .
FMDV contains 60 copies each of four proteins (VP1 to VP4) that form an icosahedral particle encapsidating a positive-sense, single-stranded RNA genome of approximately 8,500 nucleotides (3). Examinations of virus structure by monoclonal antibody (MAb) analysis (5, 9, 42, 46) , nucleic acid sequencing of neutralization-resistant mutants (6, 14, (44) (45) (46) (47) , and X-ray crystallographic analysis have revealed that the major immunogenic sites on FMDV (1), as well as on other picornaviruses (22, 38) , involve conformational epitopes.
Rweyemamu et al. (41) have shown that FMDV type A empty capsids (subviral particles lacking nucleic acid) are as immunogenic as virions in guinea pigs and that antisera raised against empty capsids have the same serological specificity in neutralization tests as do sera prepared against virions. By MAb analysis, we have demonstrated that empty virus capsids isolated from infected cells antigenically resemble virus particles (21) . Furthermore, we and others have shown that, in a cell-free translation system programmed with FMDV RNA or subgenomic RNA transcripts, viral structural proteins self-assemble into various capsid intermediates (12, 18, 21) . On the basis of these results, a goal of ours has been to utilize recombinant DNA technology to construct FMDV clones that can express, in an appropriate host, conformationally correct immunogens that lack nucleic acid and could make effective and safe vaccines.
Previously, we described the construction of recombinant cDNA clones representing the complete FMDV coding region (34, 53) . By utilizing these constructs in this study, we produced additional clones containing either the structural protein precursor (P1) gene or the P1 gene and the viral 3C gene, which encodes the protease responsible for most of the cleavages within the P1 protein. These clones, under control of a bacteriophage T7 promoter, were expressed in an Escherichia coli system. The construct containing only the P1 gene was also used to produce an infectious baculovirus recombinant. In this communication, the synthesis and processing of these gene products are examined. Furthermore, the ability of the gene products to assemble correctly and their immunogenicity in guinea pigs are evaluated.
MATERIALS AND METHODS
Enzymes and chemicals. Restriction endonucleases, T4 DNA ligase, the large fragment of DNA polymerase I (Klenow fragment), and calf intestinal alkaline phosphatase were purchased from New England Biolabs, Inc., and Boehringer Mannheim Biochemicals. E. coli BL21(DE3) (48) was kindly provided by J. Dunn, Brookhaven National 20 PFU per cell and labeled with [35S]methionine after the appearance of cytopathic effects. After labeling, the cells were washed and lysed as previously described (13) .
In vitro translation. Preparation of rabbit reticulocyte lysates and the conditions for in vitro protein synthesis were as previously described (19) .
Western blotting (immunoblotting). FMDV proteins were detected immunologically following Western blotting as described by Towbin et al. (51), by using a semidry blotter and nitrocellulose membranes. The blots were blocked by using 3% nonfat dry milk in PBS and incubated overnight at 4°C with rabbit or bovine serum against inactivated FMDV or bovine convalescent serum (1:100 or 1:200). Antibody binding was detected by incubation for 2 h with approximately 500,000 cpm of 125I-labeled acid-treated FMDV per ml or with iodinated recombinant protein A/G (17, 33) .
MAbs. The MAbs were produced at our Center by following protocols previously detailed (31, 45, 46) . In brief, the immune cells were elicited in BALB/c mice by either inoculation of killed virus or virion fragments or by FMDV infection and fused with the 6X63-Ag8.653 myeloma cells of Kearney et al. (24) . The MAbs were classified by epitope location (5, 9, 42, 46) , which was based upon determination of the least structurally complex particle with which the MAb reacted (i.e., the 140S virion, the 12S protein subunit [12Sps], or individual viral proteins).
Sandwich enzyme-linked immunosorbent assay (ELISA). Anti-FMDV antibodies were purified (i.e., by ammonium sulfate precipitation and protein A-Sepharose affinity chromatography) from the sera of rabbits that had been given four 100-,ug subcutaneous inoculations of purified FMDV A12 at 4-week intervals (26) . Cross-reactions between the rabbit anti-FMDV and the mouse MAbs were eliminated by immunoadsorption. A 1:200 dilution of rabbit anti-FMDV antibodies (catcher) in 0.05 M Na2CO3-NaHCO3 (pH 9.6) was adsorbed onto plastic overnight at 4°C (Nunc Immunoplates II; GIBCO-Europe Ltd). The remaining protein-binding capacity of the plastic was saturated with blocking buffer composed of 3% bovine serum albumin and 0.05% Tween 20 in PBS for 1 h at 37°C. Antigens were bound to the coated plastic by incubation overnight at 4°C and then reacted with undiluted tissue culture supernatants of various MAbs for 30 min at 37°C and 15 min at 4°C. The MAbs bound to the plastic were detected by an ELISA procedure performed as previously described (45) .
Vaccination. Mature Dunkin-Hartley guinea pigs were vaccinated under the loose skin just off the dorsal midline over the rib cage with 2 ml of an antigen preparation per animal. A booster vaccination was administered 96 days after the primary vaccination. The antigen preparations contained equal volumes of lysed cells at a protein concentration of 3 to 4 mg/ml, emulsified in Freund's complete adjuvant. On the basis of the results obtained (see Fig. 3 (Fig. 3, 4, ft.. serum. Upon induction, cells containing pTP12X3P produced immunologically reactive proteins comigrating with P1, VP3-VP1, VPO, VP3, VP1, and 3C, while cells containing p7P12B produced reactive P1-P2' and lesser amounts of P1-2A (Fig. 4A and B) . In Sf9 cells infected with JP12B, only a protein comigrating with P1-2A was reactive by Western blot analysis (Fig. 4A) , although this recombinant virus contains the same FMDV coding region as p7P12B.
The kinetics of induction of FMDV proteins in E. coli and in infected Sf9 cells were analyzed by Western blot analysis (Fig. 5) . FMDV proteins induced in E. coli containing pTP12X3P reproducibly accumulated for only 2 h, and subsequently the cells eliminated this plasmid (data not shown). FMDV proteins produced by cells containing p7P12B generally accumulated for at least 4 h (Fig. 5) (Fig. 6) . A peak of radioactivity migrated in the region of the empty capsid marker (70S) (Fig. 6A) . SDS-PAGE analysis of this peak showed that it contained only structural proteins VPO, VP3, and VP1 (Fig. 6B) . The identities of these proteins were confirmed by Western blotting (data not shown).
Immunological were induced with IPTG for 4 or 2 h, respectively, and cells were lysed, while a cytoplasmic extract was prepared 4 (data not shown). Therefore, all subsequent experiments were performed with undiluted antigen.
Products synthesized in the E. coli(pTP12X3P) system reacted with a class I neutralizing MAb, two class II neutralizing MAbs, and two class IV MAbs (Table 1 ). All three of these MAb classes react with epitopes whose integrity requires complex viral or viral subunit structure. In addition, several class III neutralizing antibodies (sequential epitopes) and a class V nonneutralizing antibody reacted with the products (Table 1) . FMDV protein P1-2A produced in JP12B-infected Sf9 cells reacted with one class IV MAb (and weakly with a second) and also with a class V MAb (Table  1) . FMDV P1-P2' synthesized in induced E. coli containing p7P12B reacted weakly with the same class IV and V MAbs as P1-2A (Table 1) . A class II MAb, 23FB4, and two class IV MAbs, 12AF4 and 31IH7, were elicited with FMDV serotypes A5 Spain, 01 Brugge, and Asia-1, respectively. The structures recognized by these MAbs are common to at least several other serotypes (9, 44) .
Vaccination of guinea pigs. The five guinea pigs vaccinated with lysed cells expressing pTP12X3P demonstrated a neutralizing antibody response after one vaccination, and the titers of the surviving animals increased significantly after the booster vaccination ( Both products reacted with a class IV, 12S-specific MAb (Table 1) , but only the soluble product was able to induce a neutralizing antibody response in guinea pigs (Table 2 ). This is the first demonstration that a picornavirus structural protein precursor is able to elicit a neutralizing antibody response in animals.
Assembly of picornavirus structural proteins into virus particles is a complex process involving many steps. The initial step is synthesis of a protomer which contains one copy of each of the four structural proteins. ing of the protomer to VPO, VP3, and VP1 occurs immediately upon synthesis and, thus, prior to its assembly into a pentamer (39) . Empty capsids are formed by assembly of pentamers and entrance of an RNA molecule and processing of VPO to VP4 and VP2 results in formation of mature virions. The role, if any, that an unprocessed protomer, or perhaps an unprocessed pentamer, might have in inducing an immune response in animals has not been evaluated. Our results obtained with recombinant baculovirus JP12B suggest that folding of P1 occurs, since it was recognized in a solid-phase radioimmunoassay by a MAb which reacts only with acid-derived 12S structures and not with any of the individual structural proteins (45, 47) . Furthermore, P1, either as a protomer or as a more complex structure, was able to elicit a neutralizing antibody response in guinea pigs.
Our results obtained with the bacterial expression system containing plasmid pTP12X3P demonstrate the assembly of FMDV empty capsids and, perhaps, 14S pentamers. However, the process is clearly inefficient. This is in contrast to the efficient morphogenesis of FMDV in infected tissue culture cells. Thus, we have been unable to produce sufficient amounts of empty capsids or other complexes to allow us to purify these antigens and directly examine their immunogenic potential in experimental animals.
There are a number of possible reasons for inefficient assembly of FMDV capsid structures in the E. coli expression system. For example, it has recently been shown for all picornaviruses examined, including FMDV, that the aminoterminal glycine of VP4 is myristoylated (11, 32) . This modification occurs initially on the P1 precursor protein (11, 32) . The importance of this modification has been examined with poliovirus myristoylation-negative mutants. In this system, the late steps of virus assembly are inhibited and the reduced level of mature virions produced is not infectious (27, 29) . Thus, it has been speculated that myristoylation of P1 and VPO functions as an anchorage site for maintenance of a high concentration of protomers and pentamers at the membrane site where capsid assembly is believed to occur (10, 27, 29) .
Our FMDV constructs contain four additional codons, including an initiating methionine codon, upstream of the amino-terminal glycine of VP4. Thus, in these constructs, the proposed consensus myristoylation signal, glycine-X-X-X-Ser/Thr, where X represents any amino acid (11), has been altered. Furthermore, E. coli contains no detectable myristoyl-coenzyme A:protein N-myristoyltransferase activity, the enzyme responsible for protein myristoylation (16) . Recently, however, Duronio et al. (16) have reconstituted the Saccharomyces cerevisiae myristoyl-coenzyme A:protein N-myristoyltransferase system in E. coli. Therefore, it is now feasible to determine whether myristoylation of FMDV P1, containing the proposed amino-terminal consensus myristoylation signal, results in more efficient assembly of FMDV capsid intermediate structures in an E. coli expression system containing the S. cerevisiae myristoylcoenzyme A: protein N-myristoyltransferase gene.
The apparent toxic effect of the 3C protease in our bacterial expression system also clearly limits the level of synthesis and assembly possible. Alternative strategies to circumvent this problem include placing the P1 and 3C genes under the control of different promoters and expressing the 3C gene product only after substantial P1 has been synthesized. In addition, isolation of a recombinant baculovirus containing both the P1 and 3C genes may also result in higher levels of production of FMDV empty capsids than possible in the E. coli system. For example, poliovirus empty capsids have been purified from Sf9 cells infected with a recombinant baculovirus containing the entire coding region of poliovirus type 3 (52) . However, in contrast to the level of production of P1-2A in our system, Roosien et al. (36) (20) .
